| Title : Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder - DeVito_2019_J.Subst.Abuse.Treat_107_29 |
| Author(s) : DeVito EE , Carroll KM , Babuscio T , Nich C , Sofuoglu M |
| Ref : J Subst Abuse Treat , 107 :29 , 2019 |
| Abstract : DeVito_2019_J.Subst.Abuse.Treat_107_29 |
| ESTHER : DeVito_2019_J.Subst.Abuse.Treat_107_29 |
| PubMedSearch : DeVito_2019_J.Subst.Abuse.Treat_107_29 |
| PubMedID: 31757262 |
| Title : Double-Blind Placebo-Controlled Trial of Galantamine for Methadone-Maintained Individuals With Cocaine Use Disorder: Secondary Analysis of Effects on Illicit Opioid Use - Carroll_2019_Am.J.Addict_28_238 |
| Author(s) : Carroll KM , DeVito EE , Yip SW , Nich C , Sofuoglu M |
| Ref : Am J Addict , 28 :238 , 2019 |
| Abstract : Carroll_2019_Am.J.Addict_28_238 |
| ESTHER : Carroll_2019_Am.J.Addict_28_238 |
| PubMedSearch : Carroll_2019_Am.J.Addict_28_238 |
| PubMedID: 31165574 |
| Title : Feasibility and effects of galantamine on cognition in humans with cannabis use disorder - Sugarman_2019_Pharmacol.Biochem.Behav_181_86 |
| Author(s) : Sugarman DE , De Aquino JP , Poling J , Sofuoglu M |
| Ref : Pharmacol Biochem Behav , 181 :86 , 2019 |
| Abstract : Sugarman_2019_Pharmacol.Biochem.Behav_181_86 |
| ESTHER : Sugarman_2019_Pharmacol.Biochem.Behav_181_86 |
| PubMedSearch : Sugarman_2019_Pharmacol.Biochem.Behav_181_86 |
| PubMedID: 31082417 |
| Title : The Cholinergic System as a Treatment Target for Opioid Use Disorder - Jensen_2018_CNS.Drugs_32_981 |
| Author(s) : Jensen KP , DeVito EE , Yip S , Carroll KM , Sofuoglu M |
| Ref : CNS Drugs , 32 :981 , 2018 |
| Abstract : Jensen_2018_CNS.Drugs_32_981 |
| ESTHER : Jensen_2018_CNS.Drugs_32_981 |
| PubMedSearch : Jensen_2018_CNS.Drugs_32_981 |
| PubMedID: 30259415 |
| Title : Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt - MacLean_2018_Hum.Psychopharmacol__e2665 |
| Author(s) : MacLean RR , Waters AJ , Brede E , Sofuoglu M |
| Ref : Hum Psychopharmacol , :e2665 , 2018 |
| Abstract : MacLean_2018_Hum.Psychopharmacol__e2665 |
| ESTHER : MacLean_2018_Hum.Psychopharmacol__e2665 |
| PubMedSearch : MacLean_2018_Hum.Psychopharmacol__e2665 |
| PubMedID: 29926988 |
| Title : Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence: A Randomized Clinical Trial - Carroll_2017_J.Clin.Psychiatry_79_ |
| Author(s) : Carroll KM , Nich C , DeVito EE , Shi JM , Sofuoglu M |
| Ref : J Clin Psychiatry , 79 : , 2017 |
| Abstract : Carroll_2017_J.Clin.Psychiatry_79_ |
| ESTHER : Carroll_2017_J.Clin.Psychiatry_79_ |
| PubMedSearch : Carroll_2017_J.Clin.Psychiatry_79_ |
| PubMedID: 29286595 |
| Title : Cognitive Function as a Trans-Diagnostic Treatment Target in Stimulant Use Disorders - Sofuoglu_2016_J.Dual.Diagn__0 |
| Author(s) : Sofuoglu M , DeVito EE , Waters AJ , Carroll KM |
| Ref : J Dual Diagn , :0 , 2016 |
| Abstract : Sofuoglu_2016_J.Dual.Diagn__0 |
| ESTHER : Sofuoglu_2016_J.Dual.Diagn__0 |
| PubMedSearch : Sofuoglu_2016_J.Dual.Diagn__0 |
| PubMedID: 26828702 |
| Title : Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report - Sofuoglu_2012_Psychopharmacology.(Berl)_224_413 |
| Author(s) : Sofuoglu M , Herman AI , Li Y , Waters AJ |
| Ref : Psychopharmacology (Berl) , 224 :413 , 2012 |
| Abstract : Sofuoglu_2012_Psychopharmacology.(Berl)_224_413 |
| ESTHER : Sofuoglu_2012_Psychopharmacology.(Berl)_224_413 |
| PubMedSearch : Sofuoglu_2012_Psychopharmacology.(Berl)_224_413 |
| PubMedID: 22700039 |
| Title : Galantamine improves sustained attention in chronic cocaine users - Sofuoglu_2011_Exp.Clin.Psychopharmacol_19_11 |
| Author(s) : Sofuoglu M , Waters AJ , Poling J , Carroll KM |
| Ref : Experimental & Clinical Psychopharmacology , 19 :11 , 2011 |
| Abstract : Sofuoglu_2011_Exp.Clin.Psychopharmacol_19_11 |
| ESTHER : Sofuoglu_2011_Exp.Clin.Psychopharmacol_19_11 |
| PubMedSearch : Sofuoglu_2011_Exp.Clin.Psychopharmacol_19_11 |
| PubMedID: 21341919 |
| Title : Cognitive enhancement as a pharmacotherapy target for stimulant addiction - Sofuoglu_2010_Addiction_105_38 |
| Author(s) : Sofuoglu M |
| Ref : Addiction , 105 :38 , 2010 |
| Abstract : Sofuoglu_2010_Addiction_105_38 |
| ESTHER : Sofuoglu_2010_Addiction_105_38 |
| PubMedSearch : Sofuoglu_2010_Addiction_105_38 |
| PubMedID: 20078461 |
| Title : Cholinergic functioning in stimulant addiction: implications for medications development - Sofuoglu_2009_CNS.Drugs_23_939 |
| Author(s) : Sofuoglu M , Mooney M |
| Ref : CNS Drugs , 23 :939 , 2009 |
| Abstract : Sofuoglu_2009_CNS.Drugs_23_939 |
| ESTHER : Sofuoglu_2009_CNS.Drugs_23_939 |
| PubMedSearch : Sofuoglu_2009_CNS.Drugs_23_939 |
| PubMedID: 19845415 |